UK markets closed

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.55000.0000 (0.00%)
At close: 10:45AM EDT

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Building A
Fosun Technology Park No. 1289 Yishan Road
Shanghai 200233
China
86 21 3398 7000
https://www.fosunpharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees40,370

Key executives

NameTitlePayExercisedYear born
Mr. Kexin WangExecutive Co-Chairman2.11MN/A1965
Mr. Yifang WuExecutive Chairman1.68MN/A1969
Mr. Deyong WenJoint President,CEO & Executive Director1.38MN/A1971
Ms. Xiaohui GuanExecutive Vice Chairman1.26MN/A1971
Mr. Shengli LiExecutive President & Chief Growth OfficerN/AN/A1974
Ms. Rongli FengExecutive President, Chief Human Resources Officer & GM of Human Resources DepartmentN/AN/A1975
Ms. Jing LiExecutive President and CEO of Established Medicines Manufacturing & Supply DivisionN/AN/A1972
Mr. Wang Xingli M.D., Ph.D.Executive President, Co-CEO of Innovative Medicines Division and CEO of Global R&D CenterN/AN/A1962
Mr. Wenjie ZhangExecutive President & Co-CEO of Innovative Drug DivisionN/AN/A1967
Ms. Xiaolei WuVP & CFON/AN/A1980
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, anti-infection, API's and intermediate, metabolism, alimentary system, cardiovascular and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services, and investment management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Corporate governance

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s ISS governance QualityScore as of 1 May 2024 is 6. The pillar scores are Audit: 1; Board: 7; Shareholder rights: 10; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.